The arrival of fresh leadership at BMJ, the leading global Medical Publishing company, coincided with some long developing trends reaching the tipping point. The Group’s venerable and prestigious portfolio of journals, with diverse audiences, partners and product strategies, needed to find the most advantageous answers to multiple strategic shifts –including digital first business and commercial models, threatening ‘open platform’ competition, and changing needs across both customer and contributor groups.
We were tasked to help develop and agree new strategies at both Group and portfolio level, which would together enable the Group to sustain its core values, impact and quality while taking advantage of opportunities to sharpen competitiveness, realise potential value in the portfolio, and maintain relevance in a new era.
“Q5 were dedicated, insightful and passionate about helping us find the right way through a complex set of strategic challenges. They worked closely with our team to make sure our strategies focused on our true priorities and reflected the actual realities of our business, and kept us focused on not just coming through an uncertain time, but finding ways to thrive and perform”
